A Young Biotech ETF With A Lot of Potential
September 10, 2019 at 08:00 AM EDT
The Global X Genomics & Biotechnology ETF ( GNOM n/a ) debuted earlier this year, making it one of the newest additions to the biotech ETFs fray, but despite its rookie status, GNOM is a fund with ample potential for risk-tolerant, long-term investors.